Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal SERPINI1 Primary Antibody for ELISA, WB - ABIN250406
Onda, Belorgey, Sharp, Lomas: Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies. in The Journal of biological chemistry 2005
Human Monoclonal SERPINI1 Primary Antibody for IHC (p), ELISA - ABIN562219
Prunotto, Farina, Lane, Pernin, Schifferli, Hochstrasser, Lescuyer, Moll: Proteomic analysis of podocyte exosome-enriched fraction from normal human urine. in Journal of proteomics 2013
Results report the identification of Spn4A, a previously uncharacterized secretory pathway serine protease inhibitor (serpin) from Drosophila melanogaster that contains a consensus furin (show FURIN Antibodies) cleavage site.
Spn4 gene represents a versatile defence tool kit that may provide multiple antiproteolytic functions.
the protective effect of neuroserpin maybe independent from its canonical interaction with a tissue-type plasminogen activator (show PLAT Antibodies)
Brain metastatic cells from lung cancer and breast cancer express high levels of anti-plasminogen (show PLG Antibodies) activator (PA) serpins, including neuroserpin and serpin B2, to prevent plasmin (show PLG Antibodies) generation and its metastasis-suppressive effects.
Data indicate that the neuroprotective effect of neuroserpin is due to inhibition of plasmin (show PLG Antibodies)-mediated excitotoxin-induced cell death and is independent of neuroserpin's ability to inhibit tissue plasminogen activator (show PLAT Antibodies) activity.
Neuroserpin reduces microglial activation and, therefore, plasminogen (show PLG Antibodies) activator levels; it has a neuroprotective role after focal ischemic stroke.
Neuroserpin mRNA is widely expressed in neuronal cells in the primary visual cortex during normal development as well as in the adult mouse.
Our results implicate neuroserpin in the regulation of emotional behavior through a mechanism that is at least in part independent of tissue type plasminogen activator (show PLAT Antibodies) activity
neuroserpin levels appear to be carefully regulated by LRP (show LRP1 Antibodies) and an unidentified cofactor, and this pathway may be critical for maintaining the balance between proteases and inhibitors
Altogether, these data suggest that an overexpression of neuroserpin in the brain parenchyma might limit the deleterious effect of tPA (show PLAT Antibodies) on NMDA receptor-mediated neuronal death, which occurs following experimental ischemia.
Transgenic mice overexpressing neuroserpin have decreased plasminogen (show PLG Antibodies) activators in sciatic nerve and spinal cord, confirming a role for neuroserpin in the evolution of a neurodegenerative disease.
the existence of an AMH (show AMH Antibodies)-dependent signalling pathway in the brain leading to an overexpression of the serine-protease inhibitor, neuroserpin, and neuronal survival
Data indicated that rs9853967 and rs11714980 polymorphisms in CCM3 (show PDCD10 Antibodies) and SERPINI1respectively could be associated with a protective role in cerebral cavernous malformations disease.
SERPINI1 is an important regulator of epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancer
This C-terminal lability is not required for neuroserpin polymerisation in the endoplasmic reticulum, but the additional glycan facilitates degradation of the mutant protein during proteasomal impairment.
Neuroserpin is expressed in naive effector memory and central memory CD4 (show CD4 Antibodies) and CD8 (show CD8A Antibodies) T cell subsets, and monocytes, B cells, and NK cells. T-cell activation caused its translocation to the immunologic synapse, secretion, and delayed downregulation.
Molecular Dynamics simulations suggest that Neuroserpin conformational stability and flexibility arise from a spatial distribution of intramolecular salt-bridges and hydrogen bonds.
Alzheimer's disease brain tissues with elevated neuroserpin protein also showed increased expression of THRbeta1 and HuD (show ELAVL4 Antibodies)
our study did not provide any evidence for an association between genetic variation at the SERPINI1 locus and ischemic stroke
Neuroprotective properties of neuroserpin may be related to the inhibition of excitotoxicity, inflammation, as well as blood brain barrier disruption that occur after acute ischemic stroke.
Hrd1 (show SYVN1 Antibodies) and gp78 (show AMFR Antibodies) mediate mutant neuroserpin turnover through the ERAD pathway.
This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified.
, serine protease inhibitor 4
, serpin 4
, serpin 42Da
, serpin peptidase inhibitor, clade I (neuroserpin), member 1
, peptidase inhibitor 12
, protease inhibitor 17
, serine protease inhibitor 17
, serpin I1
, serine (or cysteine) proteinase inhibitor, clade I (neuroserpin), member 1
, serine (or cysteine) peptidase inhibitor, clade I, member 1
, serine (or cysteine) proteinase inhibitor clade member 1
, serpin peptidase inhibitor, clade I, member 1